# Neoadjuvant POF in the Treatment of Locally Advanced Gastric Cancer

> **NCT04149015** · PHASE2 · UNKNOWN · sponsor: **Fujian Cancer Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** paclitaxel ,oxaliplatin,fluorouracil

## Key facts

- **NCT ID:** NCT04149015
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04149015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04149015, "Neoadjuvant POF in the Treatment of Locally Advanced Gastric Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04149015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*